Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 385Myelodysplastic Syndromes 153Leukemia, Myelomonocytic, Chronic 76Leukemia 65Recurrence 27Hematologic Neoplasms 20Myeloproliferative Disorders 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Anemia, Refractory, with Excess of Blasts 14Neoplasms 13Neoplasm, Residual 11Multiple Myeloma 11Leukemia, Monocytic, Acute 11Leukemia, Lymphocytic, Chronic, B-Cell 11Leukemia, Biphenotypic, Acute 11Lymphoma, Non-Hodgkin 10Leukemia, Myelomonocytic, Acute 10Primary Myelofibrosis 9Leukemia, Erythroblastic, Acute 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Myelodysplastic-Myeloproliferative Diseases 8Lymphoma 8Leukemia, Myeloid 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Megakaryoblastic, Acute 8Congenital Abnormalities 8Leukemia, Myelomonocytic, Juvenile 5Hodgkin Disease 5GATA2 Deficiency 5Lymphoma, Large B-Cell, Diffuse 4

Interventions

Tretinoin 1Therapeutics 1Restraint, Physical 1Nutritional Support 1Geriatric Assessment 1Exercise 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Frailty × Azacitidine × Other hematologic neoplasm × Clear all
NCT05175508 2022-01-03

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

The First Affiliated Hospital of Soochow University

Phase 2/3 Unknown
180 enrolled
MyeloidOther hematologic neoplasm

Frailty, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡